PTC Therapeutics' Series H Round

PTC Therapeutics raised a round of funding on July 23, 2012.

PTC Therapeutics (PTC) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small-molecule drugs that target post-transcriptional control …

Articles about PTC Therapeutics' Series H Round: